Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Lymphoma"" wg kryterium: Temat


Starter badań:

Tytuł :
Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive.
Autorzy :
Ahrendsen JT; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Oklahoma City Office of the Chief Medical Examiner, Oklahoma City, OK, USA.
Ta R; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Li J; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Weinberg OK; University of Texas-Southwestern Medical Center, Dallas, TX, USA.
Ferry JA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Meredith DM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Varma H; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Sadigh S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Michaels PD; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Pokaż więcej
Źródło :
American journal of clinical pathology [Am J Clin Pathol] 2022 Aug 04; Vol. 158 (2), pp. 300-310.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/diagnosis
Lymphoma, Large-Cell, Anaplastic*/genetics
Lymphoma, Large-Cell, Anaplastic*/pathology
Adolescent ; Anaplastic Lymphoma Kinase/genetics ; Central Nervous System/pathology ; Female ; Humans ; In Situ Hybridization, Fluorescence ; Male ; Receptor Protein-Tyrosine Kinases/genetics ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: a single-center KwaZulu-Natal, South African hospital 12-year retrospective review.
Autorzy :
Rapiti N; Department of Haematology, NHLS/University of KwaZulu Natal/King Edward VIII Hospital, Durban, South Africa. .
Abdelatif N; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa.
Rapiti A; Department of Neurosurgery, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Moosa MY; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
Pokaż więcej
Źródło :
Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2022 Aug 01; Vol. 34 (1), pp. 32. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
HIV Infections*/epidemiology
Lymphoma*/chemically induced
Lymphoma*/drug therapy
Lymphoma*/epidemiology
Adult ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/therapeutic use ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Female ; HIV ; Hospitals ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Male ; Prednisone/adverse effects ; Prednisone/therapeutic use ; Retrospective Studies ; Rituximab/therapeutic use ; South Africa/epidemiology ; Treatment Outcome ; Vincristine/therapeutic use
Czasopismo naukowe
Tytuł :
Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Autorzy :
Eze C; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Friedrich I; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Hadi I; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Hartoyo SN; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Trauth R; Schön Klinik München Harlaching, München, Germany.
Reitz D; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Manapov F; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Siefert A; Department of Radiotherapy, Strahlentherapie Radiologie München, München, Germany.
Dreyling M; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.
Belka C; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, Munich, Germany.
Li M; Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.
Pokaż więcej
Źródło :
European journal of haematology [Eur J Haematol] 2022 Jul; Vol. 109 (1), pp. 21-30. Date of Electronic Publication: 2022 Mar 22.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/pathology
Lymphoma, B-Cell, Marginal Zone*/radiotherapy
Orbital Neoplasms*/diagnosis
Orbital Neoplasms*/pathology
Orbital Neoplasms*/radiotherapy
Humans ; Lymphoma ; Middle Aged ; Neoplasm Recurrence, Local ; Recurrence ; Retrospective Studies ; Treatment Outcome
SCR Disease Name :
Orbital lymphoma
Czasopismo naukowe
Tytuł :
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
Autorzy :
Xia M; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
David L; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts.
Teater M; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Gutierrez J; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Wang X; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Meydan C; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
Lytle A; Centre for Lymphoid Cancer, BC Cancer Research, Vancouver, British Columbia, Canada.
Slack GW; Centre for Lymphoid Cancer, BC Cancer Research, Vancouver, British Columbia, Canada.
Scott DW; Centre for Lymphoid Cancer, BC Cancer Research, Vancouver, British Columbia, Canada.
Morin RD; Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
Onder O; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Elenitoba-Johnson KSJ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Zamponi N; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Cerchietti L; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Lu T; Janssen Research & Development, Springhouse, Pennsylvania.
Philippar U; Janssen Research & Development, Beerse, Belgium.
Fontan L; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Wu H; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts.
Melnick AM; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Pokaż więcej
Źródło :
Cancer discovery [Cancer Discov] 2022 Aug 05; Vol. 12 (8), pp. 1922-1941.
Typ publikacji :
Journal Article
MeSH Terms :
B-Cell CLL-Lymphoma 10 Protein*/genetics
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
CARD Signaling Adaptor Proteins/genetics ; Guanylate Cyclase/genetics ; Humans ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein/genetics ; Mutation ; Signal Transduction
Czasopismo naukowe
Tytuł :
RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma.
Autorzy :
Ahmed N; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Ketterling RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Dasari S; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Feldman AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Histopathology [Histopathology] 2022 Aug; Vol. 81 (2), pp. 275-278. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Letter
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/genetics
Lymphoma, Large-Cell, Anaplastic*/pathology
Anaplastic Lymphoma Kinase/genetics ; Gene Rearrangement ; Humans ; Proto-Oncogene Proteins c-bcl-6/genetics ; Transcription Factors/genetics ; Tumor Suppressor Proteins/genetics
Opinia redakcyjna
Tytuł :
Pulmonary MALT lymphoma: Imaging findings in 18 cases and the associated pathological correlations.
Autorzy :
Wu T; Department of Respiratory, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China.
Huang Y; Department of Radiology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China.
Wang Z; Department of Pathology, The Affiliated Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang, China.
Cao H; Department of Radiology, The Affiliated Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang, China.
Ding Q; Department of Respiratory, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China.
Deng Z; Department of Respiratory, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China. Electronic address: .
Pokaż więcej
Źródło :
The American journal of the medical sciences [Am J Med Sci] 2022 Aug; Vol. 364 (2), pp. 192-197. Date of Electronic Publication: 2022 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Lung Neoplasms*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/diagnostic imaging
Female ; Humans ; Lung/pathology ; Lymphoma, Non-Hodgkin ; Male ; Retrospective Studies ; Stomach Neoplasms ; Tomography, X-Ray Computed/methods
SCR Disease Name :
Familial primary gastric lymphoma
Czasopismo naukowe
Tytuł :
Construction of three-gene-based prognostic signature and analysis of immune cells infiltration in children and young adults with B-acute lymphoblastic leukemia.
Autorzy :
Xiang C; Department of Hematology, Huai'an First People's Hospital Affiliated to Nanjing Medical University, Huai'an, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.
Wu J; Department of Emergency Medicine, The Fifth People's Hospital of Huai'an, Huai'an, China.
Yu L; Department of Hematology, Huai'an First People's Hospital Affiliated to Nanjing Medical University, Huai'an, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło :
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2022 Jul; Vol. 10 (7), pp. e1964. Date of Electronic Publication: 2022 May 23.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/immunology
Ephrin-B1*/genetics
Ephrin-B1*/immunology
Minor Histocompatibility Antigens*/genetics
Minor Histocompatibility Antigens*/immunology
NADPH Oxidase 2*/genetics
NADPH Oxidase 2*/immunology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/immunology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Proto-Oncogene Proteins c-bcl-2*/genetics
Proto-Oncogene Proteins c-bcl-2*/immunology
Child ; Humans ; Immune System/immunology ; Immune System/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Prognosis ; RNA, Messenger/genetics ; Young Adult
Czasopismo naukowe
Tytuł :
Treatment Outcomes of Low-grade Lymphoma of the Orbit.
Autorzy :
Holloway CL; Radiation Oncology, University of British Columbia, BC Cancer, Victoria, British Columbia, Canada. Electronic address: .
Pickles T; Radiation Oncology, University of British Columbia, BC Cancer, Vancouver, British Columbia, Canada.
Croteau NS; Department of Mathematics and Statistics, University of Victoria, Victoria, British Columbia, Canada.
Wai ES; Radiation Oncology, University of British Columbia, BC Cancer, Victoria, British Columbia, Canada.
Pokaż więcej
Źródło :
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2022 Jul; Vol. 34 (7), pp. e298-e304. Date of Electronic Publication: 2022 Feb 21.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, Non-Hodgkin*/drug therapy
Lymphoma, Non-Hodgkin*/radiotherapy
Orbital Neoplasms*/radiotherapy
Adult ; Aged ; Aged, 80 and over ; Humans ; Lymphoma ; Middle Aged ; Orbit/pathology ; Recurrence ; Retrospective Studies ; Treatment Outcome ; Young Adult
SCR Disease Name :
Orbital lymphoma
Czasopismo naukowe
Tytuł :
Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment?
Autorzy :
Raderer M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
Kiesewetter B; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
Mayerhoefer ME; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Therapy, Division of General and Pediatric, Radiology, Medical University of Vienna, Department of Biomedical Imaging and Image-guided, Vienna, Austria.
Pokaż więcej
Źródło :
Expert review of hematology [Expert Rev Hematol] 2022 Jul; Vol. 15 (7), pp. 565-571. Date of Electronic Publication: 2022 Jun 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Helicobacter pylori*
Lymphoma, B-Cell, Marginal Zone*/diagnostic imaging
Lymphoma, B-Cell, Marginal Zone*/drug therapy
Gastroscopy ; Humans ; Lymphoma, Non-Hodgkin ; Magnetic Resonance Imaging ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography ; Stomach/pathology ; Stomach Neoplasms
SCR Disease Name :
Familial primary gastric lymphoma
Czasopismo naukowe
Tytuł :
Immunophenotypic shifts during minimal residual evaluation in a case of leukemic form of anaplastic large cell lymphoma ALK.
Autorzy :
Canellas MC; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Bruno-Riscarolli E; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Ferreira-Facio CS; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Lopes-Alves DV; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Botafogo VD; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Sutter D; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Pontes RM; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Land MGP; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Department of Pediatrics, Faculty of Medicine - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Bedran Milito C; Department of Pathology, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Integrated Morphology Laboratory, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
da Costa ES; Martagão Gesteira Pediatric Institute - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Department of Pediatrics, Faculty of Medicine - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Pokaż więcej
Źródło :
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2022 Jul; Vol. 5 (7), pp. e1526. Date of Electronic Publication: 2021 Aug 11.
Typ publikacji :
Case Reports
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/diagnosis
Lymphoma, Large-Cell, Anaplastic*/pathology
Anaplastic Lymphoma Kinase ; Child ; Disease Progression ; Flow Cytometry ; Humans ; Immunophenotyping ; Neoplasm, Residual/diagnosis
Raport
Tytuł :
Coexistence of gastric and pulmonary MALT lymphoma and a clonally related, disseminated large B cell lymphoma with conspicuous angiotropism.
Autorzy :
Yoshida-Sakai N; Department of Hematology, St. Mary's Hospital, 422, Tsubuku-honmachi, Kurume, Fukuoka, 830-8543, Japan. .
Oe K; Department of Cardiology, St. Mary's Hospital, Kurume, Japan.
Kimura Y; Department of Pathology, St. Mary's Hospital, Kurume, Japan.
Ureshino H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Nomiyama K; Department of Hematology, St. Mary's Hospital, 422, Tsubuku-honmachi, Kurume, Fukuoka, 830-8543, Japan.
Hashiguchi M; Department of Hematology, St. Mary's Hospital, 422, Tsubuku-honmachi, Kurume, Fukuoka, 830-8543, Japan.
Jojima H; Department of Hematology, St. Mary's Hospital, 422, Tsubuku-honmachi, Kurume, Fukuoka, 830-8543, Japan.
Imamura Y; Department of Hematology, St. Mary's Hospital, 422, Tsubuku-honmachi, Kurume, Fukuoka, 830-8543, Japan.
Ohshima K; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Okamura T; Department of Hematology, St. Mary's Hospital, 422, Tsubuku-honmachi, Kurume, Fukuoka, 830-8543, Japan.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2022 Jun; Vol. 101 (6), pp. 1383-1385. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji :
Letter
MeSH Terms :
Helicobacter Infections*/complications
Helicobacter pylori*
Lymphoma, B-Cell, Marginal Zone*/complications
Lymphoma, B-Cell, Marginal Zone*/pathology
Lymphoma, Large B-Cell, Diffuse*/pathology
Stomach Neoplasms*/complications
Stomach Neoplasms*/pathology
Humans ; Lymphoma, Non-Hodgkin
SCR Disease Name :
Familial primary gastric lymphoma
Opinia redakcyjna
Tytuł :
Investigation of endoscopic findings in nine cases of Helicobacter suis-infected gastritis complicated by gastric mucosa-associated lymphoid tissue lymphoma.
Autorzy :
Kadota H; Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
Yuge R; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Miyamoto R; Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
Otani R; Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
Takigawa H; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hayashi R; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Urabe Y; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Oka S; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Sentani K; Department of Molecular Pathology, Hiroshima University, Hiroshima, Japan.
Oue N; Department of Molecular Pathology, Hiroshima University, Hiroshima, Japan.
Kitadai Y; Department of Health Sciences, Prefectural University of Hiroshima, Hiroshima, Japan.
Tanaka S; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Pokaż więcej
Źródło :
Helicobacter [Helicobacter] 2022 Jun; Vol. 27 (3), pp. e12887. Date of Electronic Publication: 2022 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Gastritis*/complications
Gastritis*/pathology
Helicobacter Infections*/complications
Helicobacter Infections*/diagnosis
Helicobacter Infections*/drug therapy
Helicobacter heilmannii*
Helicobacter pylori*/genetics
Lymphoma, B-Cell, Marginal Zone*/complications
Lymphoma, B-Cell, Marginal Zone*/pathology
Stomach Neoplasms*/pathology
Gastric Mucosa/pathology ; Humans ; Lymphoma, Non-Hodgkin
SCR Disease Name :
Familial primary gastric lymphoma
Czasopismo naukowe
Tytuł :
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study.
Autorzy :
Ollila T; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
Butera J; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
Egan P; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
Reagan J; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
Thomas A; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
Yakirevich I; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
MacKinnon K; Brown University Oncology Research Group (BrUOG), Providence, RI, USA.
Margolis J; Brown University Oncology Research Group (BrUOG), Providence, RI, USA.
McMahon J; Lifespan Oncology Clinical Research, Providence, RI, USA.
Rosati V; Lifespan Oncology Clinical Research, Providence, RI, USA.
Olszewski AJ; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
Pokaż więcej
Źródło :
The oncologist [Oncologist] 2022 Jul 05; Vol. 27 (7), pp. 532-e542.
Typ publikacji :
Clinical Trial, Phase I; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Lymphoma, B-Cell*/drug therapy
Adult ; Bayes Theorem ; Bendamustine Hydrochloride/therapeutic use ; Humans ; Ileus/chemically induced ; Liposomes ; Lymphopenia ; Neutropenia/chemically induced ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Rituximab/therapeutic use ; Vincristine/therapeutic use
Czasopismo naukowe
Tytuł :
MALT lymphoma associated with laryngeal amyloidosis: case report.
Autorzy :
Velasco LC; Centro Estadual de Reabilitação e Readaptação Dr. Henrique Santillo (CRER), Goiânia, GO, Brazil.
Freitas LB; Centro Estadual de Reabilitação e Readaptação Dr. Henrique Santillo (CRER), Goiânia, GO, Brazil. Electronic address: laurice_.
Garcia JL; Centro Estadual de Reabilitação e Readaptação Dr. Henrique Santillo (CRER), Goiânia, GO, Brazil.
de Paula HM; Universidade Federal de Goiás (UFG), Faculdade de Medicina, Goiânia, GO, Brazil.
Cruz VA; Universidade Federal de Goiás (UFG), Goiânia, GO, Brazil.
Ramos HVL; Centro Estadual de Reabilitação e Readaptação Dr. Henrique Santillo (CRER), Goiânia, GO, Brazil.
Costa CC; Centro Estadual de Reabilitação e Readaptação Dr. Henrique Santillo (CRER), Goiânia, GO, Brazil.
Pokaż więcej
Źródło :
Brazilian journal of otorhinolaryngology [Braz J Otorhinolaryngol] 2022 Jul-Aug; Vol. 88 (4), pp. 642-645. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Case Reports
MeSH Terms :
Amyloidosis*/complications
Amyloidosis*/pathology
Laryngeal Diseases*/complications
Laryngeal Diseases*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/complications
Lymphoma, B-Cell, Marginal Zone*/diagnostic imaging
Lymphoma, B-Cell, Marginal Zone*/pathology
Stomach Neoplasms*/complications
Stomach Neoplasms*/pathology
Humans ; Lymphoma, Non-Hodgkin
SCR Disease Name :
Familial primary gastric lymphoma
Raport
Tytuł :
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignancies.
Autorzy :
Izquierdo E; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Vorholt D; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Blakemore S; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Sackey B; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Nolte JL; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Barbarino V; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Schmitz J; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Nickel N; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Bachurski D; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Lobastova L; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Nikolic M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Michalik M; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Brinker R; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Merkel O; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Franitza M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Georgomanolis T; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; West German Genome Center (WGGC), Cologne, Germany.
Neuhaus R; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Koch M; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Nasada N; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Knittel G; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Chapuy B; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité - University Medical Center Berlin, corporate member of Free University Berlin and Humboldt-University Berlin, Berlin, Germany.
Ludwig N; Institute for Human Genetics, University of Saarland, Homburg/Saar, Germany.
Meese E; Institute for Human Genetics, University of Saarland, Homburg/Saar, Germany.
Frenzel L; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Reinhardt HC; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.; Clinic for Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, Essen, Germany; and.
Peifer M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Rebollido-Rios R; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Bruns H; Department of Internal Medicine, University of Erlangen, Erlangen, Germany.
Krüger M; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Hallek M; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Pallasch CP; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn.; Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD), and.
Pokaż więcej
Źródło :
Blood [Blood] 2022 Jun 23; Vol. 139 (25), pp. 3617-3629.
Typ publikacji :
Journal Article
MeSH Terms :
B7-H1 Antigen*/genetics
B7-H1 Antigen*/metabolism
Extracellular Vesicles*/metabolism
Lymphoma, B-Cell*/genetics
Lymphoma, B-Cell*/metabolism
Animals ; Lymphoma/metabolism ; Macrophages/metabolism ; Mice ; Neoplasms/metabolism
Czasopismo naukowe
Tytuł :
MALT lymphoma complicated with systemic AL amyloidosis.
Autorzy :
Wang D; Department of Nephrology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, China.
Fan D; Department of Nephrology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, China.
Sun M; Department of Hematology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, China.
Jiang X; Department of Hematology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, China - .
Pokaż więcej
Źródło :
Minerva surgery [Minerva Surg] 2022 Aug; Vol. 77 (4), pp. 399-401. Date of Electronic Publication: 2022 May 16.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Amyloidosis*/complications
Immunoglobulin Light-chain Amyloidosis*/complications
Lymphoma, B-Cell, Marginal Zone*/complications
Stomach Neoplasms*/complications
Humans ; Lymphoma, Non-Hodgkin
SCR Disease Name :
Familial primary gastric lymphoma
Czasopismo naukowe
Tytuł :
Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies.
Autorzy :
Loh J; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
Ang YLE; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
Jain A; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Yeong J; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Institute of Molecular Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore.; Singapore Immunology Network, Agency of Science (SIgN), Technology and Research (A*STAR), Singapore, Singapore.
Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore.
Pokaż więcej
Źródło :
JCO precision oncology [JCO Precis Oncol] 2022 Jul; Vol. 6, pp. e2200208.
Typ publikacji :
Editorial
MeSH Terms :
Gastrointestinal Neoplasms*/genetics
Lymphoma, Large-Cell, Anaplastic*/pathology
Anaplastic Lymphoma Kinase/genetics ; Humans ; Receptor Protein-Tyrosine Kinases/genetics
Opinia redakcyjna
Tytuł :
MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
Autorzy :
Yuan J; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Xiang L; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Wang F; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Zhang L; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Liu G; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Chang X; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Zhang A; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Tao Y; Department of Rheumatology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Pokaż więcej
Źródło :
Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Jul; Vol. 36 (7), pp. e24472. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, B-Cell, Marginal Zone*/metabolism
Osteoarthritis*/drug therapy
Spondylitis, Ankylosing*/drug therapy
Humans ; Inflammation/metabolism ; Interleukin-17 ; Leukocytes, Mononuclear/pathology ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein/metabolism ; Th1 Cells ; Th17 Cells/pathology ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
ALK-positive large B-cell lymphomas: A clinicopathologic study.
Autorzy :
Chandramohan J; Department of General Pathology, Christian Medical College, Vellore, Tamil Nadu, India.
Ganapule G; Department of General Pathology, Christian Medical College, Vellore, Tamil Nadu, India.
Sigamani E; Department of General Pathology, Christian Medical College, Vellore, Tamil Nadu, India.
George B; Department of Clinical Hematology, Christian Medical College, Vellore, Tamil Nadu, India.
Korula A; Department of Clinical Hematology, Christian Medical College, Vellore, Tamil Nadu, India.
Manipadam MT; Department of General Pathology, Christian Medical College, Vellore, Tamil Nadu, India.
Pokaż więcej
Źródło :
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2022 Apr-Jun; Vol. 65 (2), pp. 381-386.
Typ publikacji :
Journal Article
MeSH Terms :
Delayed Diagnosis*
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/pathology
Anaplastic Lymphoma Kinase/genetics ; Female ; Humans ; Immunohistochemistry ; Male ; Receptor Protein-Tyrosine Kinases
Czasopismo naukowe
Tytuł :
Primary central nervous system ALK-negative anaplastic large cell lymphoma: a case report and literature review.
Autorzy :
Yuan C; Department of Neurosurgery, Peking University First Hospital, Beijing, China.
Duan H; Department of Neurosurgery, Peking University First Hospital, Beijing, China.
Wang Y; Department of Neurosurgery, Peking University First Hospital, Beijing, China.
Zhang J; Department of Neurosurgery, Peking University First Hospital, Beijing, China.
Ou J; Department of Hematology, Peking University First Hospital, Beijing, China.
Wang W; Department of Pathology, Peking University First Hospital, Beijing, China.
Zhang M; Department of Radiotherapy, Peking University First Hospital, Beijing, China.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2022 Apr; Vol. 11 (4), pp. 1554-1560. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/diagnosis
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Large-Cell, Anaplastic*/pathology
Anaplastic Lymphoma Kinase ; Central Nervous System ; Humans ; Male ; Prospective Studies ; Receptor Protein-Tyrosine Kinases/metabolism ; Receptor Protein-Tyrosine Kinases/therapeutic use ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies